Back

The Drug-Induced Respiratory Disease Website and App

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Risks depends on COX-selectivity. Review and guidelines at PMID 21631520. Studies on selective rechallenge at PMID 21981353 and 23278883

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I - Interstitial/parenchymal lung disease

II - Pulmonary edema - Acute lung injury - ARDS

IV - Airway involvement

V - Pleural and/or pericardial involvement

VII - Mediastinal involvement

VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement

IX - Neuromuscular / CNS involvement - Disordered breathing (during sleep)

X - Systemic/Distant conditions, syndromes and reactions

XI - Miscellaneous

XIV - Hemoglobinopathies - Abnormal hemoglobin states (acquired)